← Eichor
Study identifier: NCT04482478 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia

Condition: Functional Dyspepsia  ·  Sponsor: Seoul National University Bundang Hospital

PhaseNA
Planned participants100
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersYes

About this study

This clinical trial was designed to evaluate the functional and safety effects on dyspeptic symptoms compared to the placebo when ingested with EDL (Extract of Dolichos lablab Linne) in adults who complain of dyspeptic symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Nayoung Kim, M.D., Ph. D.  ·  82-31-787-7008  ·  nayoung49@empas.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University Bundang HospitalSeongnam-si, Gyeonggi-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04482478